BMY vs VICR · P/E 17, rev $24.46B vs P/E 87, rev $452.7M
Bristol-Myers Squibb Company (BMY) versus Vicor Corporation (VICR) — a side-by-side from cached financials, not a winner call.
Bristol-Myers Squibb Company (BMY) is a drug manufacturers - general company listed on US. It is led by Christopher S. Boerner Ph.D..
Vicor Corporation (VICR) is a electronic components company listed on US.
Latest reported BMY revenue for 2026-06-30 was $24.46B. Net income was $5.99B. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
Latest reported VICR revenue for 2025-12-31 was $452.7M. Net income was $118.6M. Revenue was up 26.1% from 2024-12-31 to 2025-12-31. VICR currently screens at market cap $2.09B and trailing P/E 87.3.
BMY currently screens at market cap $95.36B and trailing P/E 17.5. VICR currently screens at market cap $2.09B and trailing P/E 87.3.
Not investment advice. Open the BMY and VICR stock pages for the full models.
Not investment advice.